Geoprima Solusi Tbk. vs Merck Tbk. — how do they compare? Geoprima Solusi Tbk. trades at Rp322 (market cap 240.56B, 31.77M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 27.4K 24h volume). The key difference: Merck Tbk. is far larger — about 7.1× Geoprima Solusi Tbk.'s market cap, and Geoprima Solusi Tbk. is more actively traded (31.77M versus 27.4K). Which is the better fit depends on your goals.
| GPSO | MERK | |
|---|---|---|
Market Cap | 240.56B | 1.7T |
Volume | 31.77M | 27.4K |
Lot | 317.66K | 274 |
Turnover | 10.38B | 105.16M |
Average Price | 326.77 | 3,837.88 |
Value | 10.38B | 105.16M |
Indicative Equilibrium Price | 326 | 3,850 |
Indicative Equilibrium Volume | 1.5K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Geoprima Solusi Tbk (the “Company”) was established in the Republic of Indonesia on March 6, 1997, under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Notarial Deed No. 15 dated March 6, 1997 of Jimmy Simanungkalit, S.H., Notary in Jakarta. The Company started its commercial operation in 1998.
Read more on GPSO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →